Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy

Abstract

QM1 and QM2 hybrids exhibited less IgE-binding activity but preserved immunogenicity and fulfilled the basic requirements for hypoallergenic molecules suitable for a future SIT of HDM allergy.